Adaptive Designs in Clinical Trials

Organization: SMi Group Limited

Venue: Copthorne Tara Hotel London Kensington

Location: London, United Kingdom

Event Date/Time: Apr 08, 2013 End Date/Time: Apr 09, 2018
Report as Spam


The expert speakers at Adaptive Designs in Clinical Trials are widely regarded as industry leaders.  Through their first-hand accounts and in-depth case studies you will learn how to quickly and accurately implement an adaptive design clinical trial for your drug development from initial processes in managing trials to choosing the right time to implement change. 

This is the only conference in Europe dedicated to adaptive designs.

The conference will be followed by a half-day workshop on Population Enrichment Designs.

Key topics include:

  • The motivation, promise, and success of Bayesian adaptive trial design
  • An adaptive design to explore prevention therapies for Alzheimer's Disease
  • Controlling the weighted sum of Type I and Type II errors, and implications for the design and analysis of adaptive designs
  • From preclinical studies to adaptive designs – a path to the future
  • Bayesian Variable Selection (BVS) approach for dose-response modelling
  • Adaptive sample size and modification in clinical trials: start small then ask for more?
  • Adaptive trials in pre-clinical discovery
  • Paediatric adaptation: early (stage) we practice, later perhaps we practice less
  • Designing multi-arm multi-stage clinical trials
  • Exploratory dose finding in malaria

Speakers include:

Andy Kenwright, Project Statistician, Roche Products

Emmanuel Pham, Senior Director Global R&D Statistics, Ipsen

Vladimir Anisimov, Senior Strategic Biostatistics Director, Quintiles

Christopher Jennison, Professor of Statistics, University of Bath

Frank Fleischer, Teamleader Clinical Biostatistics, Boehringer-Ingelheim

Micheal Krams, VP – Head of Neurology Franchise, Johnson & Johnson

Thomas Jaki, Researcher, Department of Mathematics and Statistics, Lancaster University

Martin Simán, Director, AstraZeneca

Jouni Kerman, Statistical Methodologist, Novartis

Alun Bedding, Director, Biostatistics and Programming Development Partners, GlazoSmithKline

and more . . .

For the in-depth programme, full speaker line-up and to register please visit the website by clicking the tab above.

Alternatively, please call Cem Tuna on +44 (0)20 7827 6736.



SMi Group Limited